Literature DB >> 23810066

Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet.

Yasuhiro Kobayashi1, Shin-ichiro Kumita, Yoshimitsu Fukushima, Keiichi Ishihara, Masaya Suda, Minoru Sakurai.   

Abstract

OBJECTIVES: (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) is a useful tool for evaluating inflammation. Because, myocardial-FDG uptake occurs with diverse physiology, it should be suppressed during evaluation of myocardial inflammation by FDG-PET/CT. Diets inducing fat-based metabolism, such as a low-carbohydrate, high-fat diet (LCHF), are used in uptake-suppression protocols. However, a complete suppression of myocardial-FDG uptake has not been established. Hence, we assessed the efficacy of 24-h carbohydrate restriction along with an LCHF diet compared to that of the conventional protocol in suppressing myocardial-FDG uptake and also compared fat and glucose metabolism between these protocols.
METHODS: Fourteen healthy volunteers agreed to undergo >24-h carbohydrate restriction (glucose, <10g) and drank an LCHF beverage an hour before FDG administration. A scan performed under conventional fasting protocol served as the control. The maximal standardized uptake values (SUVmax) of the left ventricular (LV) myocardium, and left atrium lumen (blood pool), liver, and lung fields as background, were measured. Blood sugar, free fatty acids (FFAs), insulin, and triglyceride concentrations were measured just before FDG injection and compared between the 2 protocols.
RESULTS: Global LV myocardial uptake was significantly lower with the diet-preparation protocol (SUVmax 1.31 [1.15-1.49] vs. 2.98 [1.76-6.43], p=0.001). Target-to-background ratios [myocardium-to-blood ratio (MBR), myocardium-to-lung ratio (MLR), and myocardium-to-liver ratio (MLvR)] were also significantly lower with the diet-preparation protocol [MBR: 0.75 (0.68-0.84) vs. 1.63 (0.98-4.09), p<0.001; MLR: 1.87 (1.53-2.47) vs. 4.54 (2.53-12.78), p=0.004; MLvR: 0.48 (0.44-0.56) vs. 1.11 (0.63-2.32), p=0.002]. Only insulin levels were significantly different between the subjects in each protocol group (11.3 [6.2-15.1] vs. 3.9 [2.9-6.2]).
CONCLUSION: Carbohydrate restriction together with an LCHF supplement administered 1h before FDG significantly suppressed myocardial-FDG uptake. FFAs and insulin might not directly affect myocardial-FDG uptake.
Copyright © 2013 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diagnostic techniques; Fluorodeoxyglucose; Positron emission tomography

Mesh:

Substances:

Year:  2013        PMID: 23810066     DOI: 10.1016/j.jjcc.2013.05.004

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  18 in total

1.  Optimizing radionuclide imaging in the assessment of cardiac sarcoidosis.

Authors:  John P Bois; Panithaya Chareonthaitawee
Journal:  J Nucl Cardiol       Date:  2015-08-13       Impact factor: 5.952

2.  Characterization of a highly effective preparation for suppression of myocardial glucose utilization.

Authors:  Sophia R Larson; Justin A Pieper; Edward A Hulten; Edward P Ficaro; James R Corbett; Venkatesh L Murthy; Richard L Weinberg
Journal:  J Nucl Cardiol       Date:  2019-06-24       Impact factor: 5.952

3.  Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation.

Authors:  Michael T Osborne; Edward A Hulten; Venkatesh L Murthy; Hicham Skali; Viviany R Taqueti; Sharmila Dorbala; Marcelo F DiCarli; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2016-06-08       Impact factor: 5.952

Review 4.  Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations.

Authors:  Shinichiro Kumita; Keiichiro Yoshinaga; Masao Miyagawa; Mitsuru Momose; Keisuke Kiso; Tokuo Kasai; Masanao Naya
Journal:  J Nucl Cardiol       Date:  2019-08       Impact factor: 5.952

5.  Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.

Authors:  Panithaya Chareonthaitawee; Rob S Beanlands; Wengen Chen; Sharmila Dorbala; Edward J Miller; Venkatesh L Murthy; David H Birnie; Edward S Chen; Leslie T Cooper; Roderick H Tung; Eric S White; Salvador Borges-Neto; Marcelo F Di Carli; Robert J Gropler; Terrence D Ruddy; Thomas H Schindler; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2017-10       Impact factor: 5.952

6.  Optimizing myocardial metabolism for fluorine-18 fluorodeoxyglucose positron emission tomography imaging of cardiac inflammation.

Authors:  Efstathia Andrikopoulou; Pradeep Bhambhvani
Journal:  J Nucl Cardiol       Date:  2017-04-21       Impact factor: 5.952

7.  18F-fluorodeoxyglucose use after cardiac transplant: A comparative study of suppression of physiological myocardial uptake.

Authors:  Renata Christian Martins Felix; Clécio Maria Gouvea; Christiane Cigagna Wiefels Reis; Jacqueline Sampaio Dos Santos Miranda; Ligia Beatriz Chaves Espinoso Schtruk; Alexandre Siciliano Colafranceschi; Cláudio Tinoco Mesquita
Journal:  J Nucl Cardiol       Date:  2018-06-14       Impact factor: 5.952

8.  Evaluation of a low-carbohydrate diet-based preparation protocol without fasting for cardiac PET/MR imaging.

Authors:  Felix Nensa; E Tezgah; K Schweins; J Goebel; P Heusch; K Nassenstein; T Schlosser; T D Poeppel
Journal:  J Nucl Cardiol       Date:  2016-03-18       Impact factor: 5.952

9.  The high matrix acquisition technique for imaging of atherosclerotic plaque inflammation in fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography with time-of-flight: Phantom study.

Authors:  Masaya Suda; Tomonari Kiriyama; Keiichi Ishihara; Masahisa Onoguchi; Yasuhiro Kobayashi; Minoru Sakurai; Takayuki Shibutani; Shin-Ichiro Kumita
Journal:  J Nucl Cardiol       Date:  2016-05-19       Impact factor: 5.952

10.  Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring.

Authors:  Panithaya Chareonthaitawee; Rob S Beanlands; Wengen Chen; Sharmila Dorbala; Edward J Miller; Venkatesh L Murthy; David H Birnie; Edward S Chen; Leslie T Cooper; Roderick H Tung; Eric S White; Salvador Borges-Neto; Marcelo F Di Carli; Robert J Gropler; Terrence D Ruddy; Thomas H Schindler; Ron Blankstein
Journal:  J Nucl Med       Date:  2017-08       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.